Ataxia Diagnosis and Treatment Market Report (2022 to 2030) - GlaxoSmithKline Plc, Eli Lilly & Company, GlaxoSmithKline Plc, Larimar Therapeutics, Inc. and Bluebird bio, Inc.
February 20, 2023 20:30 ET
|
Growth Plus Reports
Singapore, Feb. 20, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the Global Ataxia Diagnosis and Treatment Market is expected to clock US$ 64.62 billion...